Harbour BioMed Announces Submission of IND Application for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease ...Middle East

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Nov. 8, 2024 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and...

Hence then, the article about harbour biomed announces submission of ind application for hbm9378 skb378 in the treatment of chronic obstructive pulmonary disease was published today ( Friday 08/11/2024 - 12:56 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Harbour BioMed Announces Submission of IND Application for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease )

Also on site :

• Macy’s Valley Fair shoppers thwart Rolex watch thieves
• RCB-W vs UPW-W Dream11 Prediction, Dream11 Playing XI, Today Match 5, WPL 2026
• Motional puts AI at center of robotaxi reboot as it targets 2026 for driverless service